Patents Assigned to Frontiers Biotechnologies Col, Ltd.
  • Human immunodeficiency virus (HIV) gp41 peptide derivatives with enhanced solubility and antiviral activity
    Patent number: 7575750
    Abstract: This invention relates to gp41 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to gp41 derivatives having inhibiting activity against human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) with enhanced duration of action for the treatment of the respective viral infections.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: August 18, 2009
    Assignee: Frontiers Biotechnologies Col, Ltd.
    Inventors: Dong Xie, He Jiang